Scroll Top
Gain Therapeutics Inc.

Targeting glucocerebrosidase with structurally targeted allosteric regulators corrects abnormal phenotypes in models of Parkinson’s disease

April 12th- 15th 2022 11:20 – 11:50 a.m. ET

Learn More

Latest Articles

Clear Filters
August 8, 2024
BTIG Fireside Chat with Interim CEO Gene Mack and CMO Jonas Hannestad – Virtual Biotechnology Conference 2024
Read More
June 27, 2024
H.C. Wainwright Fireside Chat with Gene Mack – 5th Annual Neuro Perspectives Virtual Conference
Read More
June 27, 2024
Business and Corporate Update Call with interim-CEO Gene Mack
Read More